NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Singleplex IHC: Singleplex Chromogenic IHC SOP (MD Anderson)   Add to my SOP compendium

BRD ID: 2,690

Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 1410


This document details the procedure used by the MD Anderson Cancer Center, a Cancer Immune Monitoring and Analysis Center (CIMAC) site, for singleplex chromogenic immunohistochemistry (IHC) of paraffin-embedded tissue sections for the following markers: CD3, CD4, CD45RO, CD57, CD68, CD8, Foxp3, Granzyme B, PD-1, PD-L1. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network;, a Cancer Moonshot Initiative.

Documents for Download

CIMAC Singleplex IHC_MDACC.pdf [Size: 969 KB]

  • Tissue - Not specified
  • Not specified
  • Neoplastic - Not specified
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • New Articles on the GTEx Project are Now Available!

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • More...